A novel strategy for treating oncogene‐mutated tumors by targeting tumor microenvironment and synergistically enhancing anti‐PD‐1 immunotherapy
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-03-01
|
| Series: | Cancer Communications |
| Online Access: | https://doi.org/10.1002/cac2.12521 |
| _version_ | 1797248710733725696 |
|---|---|
| author | Yingqiang Liu Linjiang Tong Mengge Zhang Qi Zhang Qiupei Liu Fang Feng Yan Li Mengzhen Lai Haotian Tang Yi Chen Meiyu Geng Wenhu Duan Jian Ding Hua Xie |
| author_facet | Yingqiang Liu Linjiang Tong Mengge Zhang Qi Zhang Qiupei Liu Fang Feng Yan Li Mengzhen Lai Haotian Tang Yi Chen Meiyu Geng Wenhu Duan Jian Ding Hua Xie |
| author_sort | Yingqiang Liu |
| collection | DOAJ |
| first_indexed | 2024-04-24T20:18:55Z |
| format | Article |
| id | doaj.art-d46256d3bb8445a7a06902f1237fc7fb |
| institution | Directory Open Access Journal |
| issn | 2523-3548 |
| language | English |
| last_indexed | 2024-04-24T20:18:55Z |
| publishDate | 2024-03-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cancer Communications |
| spelling | doaj.art-d46256d3bb8445a7a06902f1237fc7fb2024-03-22T11:52:53ZengWileyCancer Communications2523-35482024-03-0144343844210.1002/cac2.12521A novel strategy for treating oncogene‐mutated tumors by targeting tumor microenvironment and synergistically enhancing anti‐PD‐1 immunotherapyYingqiang Liu0Linjiang Tong1Mengge Zhang2Qi Zhang3Qiupei Liu4Fang Feng5Yan Li6Mengzhen Lai7Haotian Tang8Yi Chen9Meiyu Geng10Wenhu Duan11Jian Ding12Hua Xie13Division of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaUniversity of Chinese Academy of Sciences Beijing P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. ChinaDivision of Antitumor Pharmacology & State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai P. R. Chinahttps://doi.org/10.1002/cac2.12521 |
| spellingShingle | Yingqiang Liu Linjiang Tong Mengge Zhang Qi Zhang Qiupei Liu Fang Feng Yan Li Mengzhen Lai Haotian Tang Yi Chen Meiyu Geng Wenhu Duan Jian Ding Hua Xie A novel strategy for treating oncogene‐mutated tumors by targeting tumor microenvironment and synergistically enhancing anti‐PD‐1 immunotherapy Cancer Communications |
| title | A novel strategy for treating oncogene‐mutated tumors by targeting tumor microenvironment and synergistically enhancing anti‐PD‐1 immunotherapy |
| title_full | A novel strategy for treating oncogene‐mutated tumors by targeting tumor microenvironment and synergistically enhancing anti‐PD‐1 immunotherapy |
| title_fullStr | A novel strategy for treating oncogene‐mutated tumors by targeting tumor microenvironment and synergistically enhancing anti‐PD‐1 immunotherapy |
| title_full_unstemmed | A novel strategy for treating oncogene‐mutated tumors by targeting tumor microenvironment and synergistically enhancing anti‐PD‐1 immunotherapy |
| title_short | A novel strategy for treating oncogene‐mutated tumors by targeting tumor microenvironment and synergistically enhancing anti‐PD‐1 immunotherapy |
| title_sort | novel strategy for treating oncogene mutated tumors by targeting tumor microenvironment and synergistically enhancing anti pd 1 immunotherapy |
| url | https://doi.org/10.1002/cac2.12521 |
| work_keys_str_mv | AT yingqiangliu anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT linjiangtong anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT menggezhang anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT qizhang anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT qiupeiliu anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT fangfeng anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT yanli anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT mengzhenlai anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT haotiantang anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT yichen anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT meiyugeng anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT wenhuduan anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT jianding anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT huaxie anovelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT yingqiangliu novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT linjiangtong novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT menggezhang novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT qizhang novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT qiupeiliu novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT fangfeng novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT yanli novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT mengzhenlai novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT haotiantang novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT yichen novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT meiyugeng novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT wenhuduan novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT jianding novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy AT huaxie novelstrategyfortreatingoncogenemutatedtumorsbytargetingtumormicroenvironmentandsynergisticallyenhancingantipd1immunotherapy |